Valneva SE VALN
NASDAQ VALN
$6.89 -0.17 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Valneva SE (VALN) Sales of Property, Plant and Equipment (2022 - 2025)

Analysis

Valneva SE (VALN) Sales of Property, Plant and Equipment (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.85 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Valneva SE 578.54 Mn 437.28 Mn 1.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 58,202.18
Sep 30, 2025 66,636.14
Jun 30, 2025 23,771.15
Sep 30, 2024 -7,687.54
Jun 30, 2024 27,999.08
Mar 31, 2024 158,608.82
Dec 31, 2023 73,163.91
Sep 30, 2023 -45.67 Mn
Jun 30, 2023 45.70 Mn
Mar 31, 2023 35,420.28
Sep 30, 2022 8,066.19